Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Molecular Cancer Research : MCR|October 10, 2014
Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shiftDoug Medvetz, Carmen Priolo, Elizabeth P HenskePlos One|April 5, 2013
MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM)Anil J Trindade, Douglas A Medvetz, Nicole A Neuman, et al.American Journal of Respiratory Cell and Molecular Biology|March 18, 2015
Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosisCarmen Priolo, Stéphane J H Ricoult, Damir Khabibullin, et al.Oncotarget|May 13, 2017
Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-RHarilaos Filippakis, Nicola Alesi, Barbara Ogorek, et al.The European Respiratory Journal|September 25, 2021
Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosisJesse D Kirkpatrick, Ava P Soleimany, Jaideep S Dudani, et al.Chest|July 13, 2019
Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient CellsYan Tang, Souheil El-Chemaly, Angelo Taveira-Dasilva, et al.Molecular Cancer Research : MCR|September 5, 2014
High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null settingDoug Medvetz, Yang Sun, Chenggang Li, et al.Urologic Oncology|May 24, 2020
Chromophobe renal cell carcinoma: New genetic and metabolic insightsLong Zhang, Elizabeth P HenskeAmerican Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 29, 2018
Pulmonary manifestations in tuberous sclerosis complexNishant Gupta, Elizabeth P HenskeOncogene|November 17, 2005
Tuberous sclerosis complex: linking growth and energy signaling pathways with human diseaseAristotelis Astrinidis, Elizabeth P HenskePageof 16